References
- Cronberg S, Wallmark E, Soederberg I. Investigations of the effect of antimicrobial drugs on platelet aggregation in vitro and ex vivo. Folia Haematol 1984; 111: 725–734.
- Fletcher C, Pearson C, Choi SC, et al. In vitro comparison of antiplatelet effects of beta-lactam penicillins. J Lab Clin Med 1986; 108: 217–223.
- Cazzola M, Santangelo G, Martucci P, Caputi M. An in vitro study of the possible interaction between human plate lets and cephalosporins. Int J Clin Pharm Res 1991; 11: 7–10.
- Nubile G, Saccone A, Di Gregorio M, Rossi M, Tresca E. L’azione degli aminoglicosidi sulla aggregazione piastrinica in vitro. Boll Soc Ital Biol Sper 1985; 61: 357–363.
- Cazzola M, Matera MG, Gusmitta A, Rossi F. Effect of flomoxef on human platelet aggregation. Eur J Clin Pharmacol 1991; 41: 503–504.
- Shattil SJ, Bennett JS, McDonough M, et al. Carbenicillin and penicillin H inhibit platelet function in vitro by impairing the interaction of agonists with platelet surface. J Clin Invest 1980; 65: 329–337.
- Bang NU, Tessler SS, Heidenreich RO, et al. Effects of moxalactam on blood coagulation and platelet function. Rev Infect Dis 1982; 4 (suppl): S546-S554.
- Nakano T, Terawaki A, Arita H. Influence of beta-lactam antibiotics on platelets. II. In vitro effects of some beta-lactam antibiotics on the biochemical responses of rat platelets. J. Pharmacobiodyn 1987; 10: 408–420.
- Cazzola M, Santangelo G, Paizis G, Matera C, Rossi F. Effects of cefonicid on platelet aggregation. Drugs Exptl Clin Res 1991; 18: 105–108.
- Sakata S, Ueda J, Hirata M. Absence of effects on platelet membrane fluidity by antibiotics in ESR spectra. Chemotherapy 1986; 32: 374–378.
- Zucker MB, Kim SJ, McPherson J, Grant RA. Binding of factor VIII to platelets in the presence of ristocetin. Br J Haematol 1977; 35: 535–549.
- Moake UL, Cimo PL, Peterson DM, Roper P, Natelson EA. Inhibition of ristocetin-induced platelet aggregation by vancomycin. Blood 1977; 50: 397–406.
- Parenti F. Glycopeptide antibiotics. J Clin Pharmacol 1988; 28: 136–140.
- Rossi F, Marrazzo R, Lucarelli C, Marabese I, De Santis D. Reicoplanin does not modify the hypoglycemic effects of phenformin or glibenclamide, nor the anticoagulant action of warfarin. Experimental study. J Chemother 1991; 3: 152–155.
- Davey PG, Williams AH. A review of the safety profile of teicoplanin. J Antimicrob Chemother 1991; 27 (suppl B): 69–73.
- Buniva G, Del Favero A, Bernareggi A, Patoia L, Palumbo R. Pharmacokinetics of 14C-teicoplanin in healthy volunteers. J Antimicrob Chemother 1988; 21 (suppl A): 23–28.
- Born GVR. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962; 194: 927–939.
- Porta M, Ricchetti I. A study of the possible interactions between human platelets and the antibiotic mdl-507 (teicoplanin). Int J Clin Pharmacol Ther Toxicol 1986; 12: 661–664.
- Agnelli G, Longetti M, Guerciolini R, et al. Effects of the new glycopeptide antibiotic teicoplanin on platelet and blood coagulation. Antimicrob Agents Chemother 1987; 31: 1609–1612.
- Rowland M. Clinical pharmacokinetics of teicoplanin. Clin Pharmacokinet. 1990; 18: 184–209.
- Gangarosa EJ, Johnson TR, Ramos HS. Ristocetininduced thrombocytopenia: site and mechanism of action. Arch Intern Med 1960; 105: 83–85.
- Turpin PJ, Taylor GP, Logan MN, Wood MJ. Teicoplanin in the treatment of skin and soft tissue infections. J Antimicrob Chemother 1988; 21 (suppl A): 117–122.
- Coronelli C, Williams DH. Chemistry of teicoplanin. In: Gialdroni-Grassi G, Mitsuhashi S, Williams DH, eds. Teicoplanin: A New Clinical Candidate for Treatment of Severe Gram-Positive Infections. Tokyo: University of Tokyo Press, 1986: 11–13.